Agilent launches new 6545XT AdvanceBio LC/Q-TOF mass spectrometry system

Agilent Technologies has announced the launch of its 6545XT AdvanceBio LC/Q-TOF mass spectrometry system for biopharmaceutical labs.

The new device is optimised to address analytical workflows commonly used in these industries, combining high-performance liquid chromatography functionality with robust quadrupole time-of-flight mass spectrometry and data-analysis tools.

It is able to deliver superior results when used in the characterisation of biomolecules that could be the basis for new therapeutics, as well as delivering high-quality results for profiling intact proteins, mapping peptides and identifying post-translational modifications.

Monty Benefiel, Agilent's vice-president and general manager of its mass spectrometry division, said: "Agilent solutions built around the 6545XT enable scientists to characterise biomolecule structure and function more efficiently than ever, resulting in reduced time to market and improved drug efficacy."

The company also announced the launch of the new AdvanceBio Peptide Plus liquid chromatography column, which has been designed specifically for LC/MS peptide separations utilising the firm's unique superficially porous particle technology.

With over 20 years of experience within the science market, we at Zenopa have the knowledge, skills and expertise to help find the right job for you. To find out more about the current science roles we have available, you can search for the latest job roles, register your details, or contact the team today.